Navigation Links
Jazz Pharmaceuticals to Present at Investor Conferences
Date:11/4/2008

PALO ALTO, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the company will present at three upcoming investor conferences.

On Tuesday, November 11, 2008 at 2:50 p.m. EST, Dr. Samuel R. Saks, Jazz Pharmaceuticals' CEO, will provide a corporate presentation at the Rodman & Renshaw 10th Annual Healthcare Conference in New York City.

On Wednesday, November 12, 2008 at 3:30 p.m. MST (5:30 p.m. EST), Dr. Saks will provide a corporate presentation at the Credit Suisse Healthcare Conference in Phoenix.

On Wednesday, November 19, 2008 at 11:30 a.m. EST, Robert M. Myers, President of Jazz Pharmaceuticals, will provide a corporate presentation at the Lazard Capital Markets 5th Annual Healthcare Conference in New York City.

A live webcast of these presentations may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on the site for two weeks following each presentation.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
3. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
4. Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
5. Genesis Pharmaceuticals Files Counter Claims
6. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
10. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
11. Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... , ... December 02, 2016 , ... More than half ... while 84 percent of parents report speaking with their child about sex related topics, ... transmitted diseases. , Mediaplanet is proud to announce the launch of its second edition ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research ... labeling, storing, shipping and disposal. The new version is a faster and a ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal ... systems and the first company to offer robotic imaging to veterinary medicine ... tradeshow booth # 941 for the American Association of Equine Practitioners 62nd Annual ...
(Date:12/2/2016)... ... 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable ... wearable health technology on the market can deliver all that rejiva can. , “Rejiva ... about their health than the usual heart rate and steps taken”, adds Evens Augustin, ...
Breaking Medicine News(10 mins):
(Date:11/30/2016)... Research and Markets has announced the addition of the ... report to their offering. ... , The cerebrospinal fluid (CSF) acts ... it is circulated though the brain and its ventricles, the spine and ... surrounding the brain changes significantly. As a result, ...
(Date:11/30/2016)... 30, 2016 Research and Markets has announced ... - MedCore" report to their offering. ... , , Detachable coil embolization ... vessel malformations. The detachable coil embolization treatment of cerebral aneurysms is less ... a weakened area in the wall of an artery in the brain. ...
(Date:11/30/2016)... PALO ALTO, Calif. , Nov. 30, 2016 /PRNewswire/ ... today announced it was named America,s Most JUST Company ... JUST Capital and Forbes magazine,s inaugural "JUST ... from one of the largest surveys ever conducted on ... last 18 months. This inaugural list ranks U.S companies ...
Breaking Medicine Technology: